Oxidation of PKGIα mediates an endogenous adaptation to pulmonary hypertension
暂无分享,去创建一个
C. Ruppert | A. Shah | R. Schermuly | Lan Zhao | T. Ida | T. Akaike | A. Weiss | P. Eaton | S. Krasemann | Min Zhang | O. Rudyk | O. Prysyazhna | K. Hartmann | Alice Rowan
[1] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[2] P. Siques,et al. Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia , 2018, Front. Physiol..
[3] L. Ignarro,et al. Biological hydropersulfides and related polysulfides – a new concept and perspective in redox biology , 2018, FEBS letters.
[4] S. Uhlig,et al. The effects of hydroxyethyl starch and gelatine on pulmonary cytokine production and oedema formation , 2018, Scientific Reports.
[5] E. Vighi,et al. New dimeric cGMP analogues reduce proliferation in three colon cancer cell lines. , 2017, European journal of medicinal chemistry.
[6] K. D. Straub,et al. Metabolism of hydrogen sulfide (H2S) and Production of Reactive Sulfur Species (RSS) by superoxide dismutase , 2017, Redox biology.
[7] Akira Nishimura,et al. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics , 2017, Nature Communications.
[8] T. Okazaki,et al. Production of reactive persulfide species in chronic obstructive pulmonary disease , 2017, Thorax.
[9] Y. Nishijima,et al. Contribution of KV1.5 Channel to Hydrogen Peroxide–Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease , 2016, Circulation research.
[10] A. Bonev,et al. Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels , 2016, Science Signaling.
[11] W. Seeger,et al. NADPH Oxidase 4 is Not Involved in Hypoxia-Induced Pulmonary Hypertension , 2016, Pulmonary circulation.
[12] A. Shah,et al. Transcriptional Regulation of Cystathionine-γ-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling , 2015, The Journal of Biological Chemistry.
[13] E. Skrzydlewska,et al. Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability , 2015, Redox biology.
[14] H. Schmidt,et al. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. , 2015, Antioxidants & redox signaling.
[15] A. Shah,et al. Deficient angiogenesis in redox-dead Cys17Ser PKARIα knock-in mice , 2015, Nature Communications.
[16] P. Eaton,et al. Redox regulation of cGMP-dependent protein kinase Iα in the cardiovascular system , 2015, Front. Pharmacol..
[17] M. Humbert,et al. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension , 2015, Circulation.
[18] A. Shah. Parsing the role of NADPH oxidase enzymes and reactive oxygen species in heart failure. , 2015, Circulation.
[19] Jenna Scotcher,et al. Protein Kinase G I&agr; Oxidation Paradoxically Underlies Blood Pressure Lowering by the Reductant Hydrogen Sulfide , 2014, Hypertension.
[20] D. Harrison,et al. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension. , 2014, American journal of physiology. Lung cellular and molecular physiology.
[21] M. Wolin,et al. Exposure of mice to chronic hypoxia attenuates pulmonary arterial contractile responses to acute hypoxia by increases in extracellular hydrogen peroxide. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] R. Macallister,et al. Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension , 2014, Circulation.
[23] M. Yeager,et al. Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease , 2014, Journal of pulmonary & respiratory medicine.
[24] Yunchao Su,et al. NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Lambeth,et al. Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor , 2014, Biochemistry.
[26] P. Eaton,et al. Biochemical methods for monitoring protein thiol redox states in biological systems , 2014, Redox biology.
[27] M. Suematsu,et al. Reactive cysteine persulfides and S-polythiolation regulate oxidative stress and redox signaling , 2014, Proceedings of the National Academy of Sciences.
[28] D. Becher,et al. Polysulfides link H2S to protein thiol oxidation. , 2013, Antioxidants & redox signaling.
[29] P. Eaton,et al. PSS171 – Redox-Dead Protein Kinase a RIα knock-in Mouse Is Not Hypertensive But Has Increased Vascular Reactivity to Oxidants , 2013 .
[30] Keng Jin Lee,et al. Isolation of pulmonary artery smooth muscle cells from neonatal mice. , 2013, Journal of visualized experiments : JoVE.
[31] T. Murphy,et al. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. , 2013, Free radical biology & medicine.
[32] M. Humbert,et al. Riociguat for the treatment of pulmonary arterial hypertension. , 2013, The New England journal of medicine.
[33] René M. Botnar,et al. Protein kinase G oxidation is a major cause of injury during sepsis , 2013, Proceedings of the National Academy of Sciences.
[34] Yuichiro J Suzuki,et al. Reactive oxygen species and antioxidants in pulmonary hypertension. , 2013, Antioxidants & redox signaling.
[35] M. Gladwin,et al. Antioxidant therapy for the treatment of pulmonary hypertension. , 2013, Antioxidants & redox signaling.
[36] R. Feil,et al. H₂O₂ lowers the cytosolic Ca²⁺ concentration via activation of cGMP-dependent protein kinase Iα. , 2012, Free radical biology & medicine.
[37] A. Shah,et al. Redox Signaling in Cardiac Physiology and Pathology , 2012, Circulation research.
[38] B. Kang,et al. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. , 2012, American journal of respiratory cell and molecular biology.
[39] P. Eaton,et al. Nitroglycerin Fails to Lower Blood Pressure in Redox-Dead Cys42Ser PKG1&agr; Knock-In Mouse , 2012, Circulation.
[40] F. Hofmann,et al. Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation. , 2012, The American journal of pathology.
[41] M. Gladwin,et al. Reactive oxygen and nitrogen species in pulmonary hypertension. , 2012, Free radical biology & medicine.
[42] M. Silva,et al. Antioxidants for Preventing Preeclampsia: A Systematic Review , 2012, TheScientificWorldJournal.
[43] W. Seeger,et al. Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. , 2012, Free radical biology & medicine.
[44] J. Cui,et al. cGMP-dependent protein kinase Iα transfection inhibits hypoxia-induced migration, phenotype modulation and annexins A1 expression in human pulmonary artery smooth muscle cells. , 2012, Biochemical and biophysical research communications.
[45] M. Wolin,et al. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia. , 2011, American journal of physiology. Heart and circulatory physiology.
[46] P. Eaton,et al. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension , 2011, Nature Medicine.
[47] Xinli Hu,et al. Exacerbated Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Animals With Loss of Function of Extracellular Superoxide Dismutase , 2011, Hypertension.
[48] H. Ghofrani,et al. Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.
[49] R. Banerjee,et al. Structural basis for substrate activation and regulation by cystathionine beta-synthase (CBS) domains in cystathionine β-synthase , 2010, Proceedings of the National Academy of Sciences.
[50] Gene Kim,et al. Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target , 2010, Circulation.
[51] A. Petry,et al. The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1 , 2010, Molecular biology of the cell.
[52] A. Firth,et al. Idiopathic pulmonary arterial hypertension , 2010, Disease Models & Mechanisms.
[53] Joseph R. Burgoyne,et al. Oxidant Sensing by Protein Kinases A and G Enables Integration of Cell Redox State with Phosphoregulation , 2010, Sensors.
[54] E. Halpern,et al. Noninvasive Assessment of Murine Pulmonary Arterial Pressure: Validation and Application to Models of Pulmonary Hypertension , 2010, Circulation. Cardiovascular imaging.
[55] A. Malik,et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. , 2009, The Journal of clinical investigation.
[56] Ping Wu,et al. NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[57] D. Robertson. Faculty Opinions recommendation of H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. , 2008 .
[58] S. Snyder,et al. H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase , 2008, Science.
[59] E. Nozik-Grayck,et al. Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[60] D. Browning. Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer , 2008, Expert opinion on therapeutic targets.
[61] Y. Sasaguri,et al. Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. , 2008, American journal of respiratory and critical care medicine.
[62] J. P. Brennan,et al. Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation , 2007, Science.
[63] L. Shimoda,et al. Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[64] W. Seeger,et al. Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature , 2007, Circulation research.
[65] T. Kawahara,et al. Regulation of Nox and Duox enzymatic activity and expression. , 2007, Free radical biology & medicine.
[66] R. Wait,et al. Oxidant-induced Activation of Type I Protein Kinase A Is Mediated by RI Subunit Interprotein Disulfide Bond Formation* , 2006, Journal of Biological Chemistry.
[67] P. Aaronson,et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies , 2006, The Journal of physiology.
[68] Yahong Chen,et al. Endogenous hydrogen sulfide in patients with COPD. , 2005, Chest.
[69] K. Krause. Tissue distribution and putative physiological function of NOX family NADPH oxidases. , 2004, Japanese journal of infectious diseases.
[70] N. Voelkel,et al. Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.
[71] B. Walker,et al. Pulmonary PKG-1 is upregulated following chronic hypoxia. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[72] N. Morrell,et al. Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension , 2001, Circulation.
[73] T. Lincoln,et al. Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. , 1999, Science.
[74] C. Packer,et al. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. , 1996, The American journal of physiology.
[75] E. Nozik-Grayck,et al. Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation. , 2017, Advances in experimental medicine and biology.
[76] S. Archer. Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications. , 2016, Advances in experimental medicine and biology.
[77] H. Ghofrani,et al. Recent Advances in Pulmonary Hypertension , 2015 .
[78] D. Browning,et al. cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment. , 2010, Future medicinal chemistry.
[79] L. Gluud,et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. , 2008, The Cochrane database of systematic reviews.
[80] E. Nozik-Grayck,et al. Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling. , 2007, Advances in experimental medicine and biology.